Share on StockTwits

Shares of Nu Skin Enterprises (NYSE:NUS) have received a consensus recommendation of “Hold” from the ten brokerages that are presently covering the company, StockRatingsNetwork reports. Three research analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $76.78.

Nu Skin Enterprises (NYSE:NUS) traded down 2.91% on Thursday, hitting $45.42. 617,823 shares of the company’s stock traded hands. Nu Skin Enterprises has a 52 week low of $43.50 and a 52 week high of $140.50. The stock’s 50-day moving average is $57.51 and its 200-day moving average is $72.97. The company has a market cap of $2.690 billion and a price-to-earnings ratio of 9.26.

Nu Skin Enterprises (NYSE:NUS) last released its earnings data on Wednesday, August 6th. The company reported $1.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.27 by $0.14. The company had revenue of $650.00 million for the quarter, compared to the consensus estimate of $709.03 million. During the same quarter in the previous year, the company posted $1.22 earnings per share. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. Analysts expect that Nu Skin Enterprises will post $4.13 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, September 26th. Shareholders of record on Friday, September 12th will be paid a dividend of $0.345 per share. This represents a $1.38 annualized dividend and a dividend yield of 2.95%. The ex-dividend date is Wednesday, September 10th.

NUS has been the subject of a number of recent research reports. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Nu Skin Enterprises in a research note on Thursday, August 7th. They now have a $70.00 price target on the stock, down previously from $110.00. Separately, analysts at Canaccord Genuity reiterated a “hold” rating on shares of Nu Skin Enterprises in a research note on Thursday, August 7th. They now have a $53.00 price target on the stock, down previously from $92.00. Finally, analysts at JPMorgan Chase & Co. downgraded shares of Nu Skin Enterprises from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 7th. They now have a $50.00 price target on the stock, down previously from $100.00.

Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.